Back to Results
First PageMeta Content



Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S. (NEW YORK and TOKYO, July 29, Kyowa Ha
Add to Reading List

Document Date: 2015-07-29 19:00:03


Open Document

File Size: 96,27 KB

Share Result on Facebook